Evaluating contrast ultrasound for detecting abdominal trauma complications

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effectiveness of contrast-enhanced ultrasound (CEUS) in identifying post-traumatic pseudoaneurysms in patients with abdominal injuries. Adult patients with confirmed splenic, hepatic, or renal trauma will undergo follow-up assessments using both CEUS and the standard CT scan to compare their efficacy. The study aims to determine if CEUS can serve as a viable alternative to CT scans for monitoring solid organ injuries after trauma. Follow-up evaluations will occur within two to five days post-injury, with additional assessments allowed during the same hospitalization.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adult patients (18 years old and above) with proven blunt or penetrating splenic and/or liver and/or renal trauma as shown by a CT scan and classified according to the American Injury Scale American Association for Surgery (AAST) Organ Injury Scale (OIS) will be included

Exclusion Criteria:

* minor to 18 years old

Where it's running

• ASST GOM Niguarda
  Milan, Italia, Italy Recruiting

Study contacts

• Study coordinator: Francesco Virdis, MD
• Email: francesco.virdis@ospedaleniguarda.it
• Phone: +393519639712

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized nutrition to help recovery after abdominal trauma

  This study is testing if a personalized nutrition plan can help ICU patients recover better after abdominal surgery from trauma compared to standard nutrition care.

  Recruiting Phase 2 Duke University · Durham, North Carolina · NCT06065202

• PSMA-guided surgery and tissue-resident T cells in node-positive prostate cancer

  This study tests whether PSMA-guided surgery can help identify and study tissue-resident T cells in prostate cancer that has spread to lymph nodes.

  Recruiting Niguarda Hospital · Milan, Lombardy · NCT07879820

• AI-powered vocal monitoring for heart failure home care

  A feasibility test to see if an AI voice-based home monitoring platform called AVATAR-SC can help people with heart failure manage their condition after hospital discharge.

  Recruiting Niguarda Hospital · Milan, Ita · NCT07664748

• Liver transplant vs removal of liver tumors after conversion therapy for initially unresectable colorectal liver metastases

  This trial tests whether liver transplantation or liver surgery with ablation best helps people whose colorectal liver metastases were initially unresectable but became potentially resectable after conversion therapy.

  Recruiting Niguarda Hospital · Milan · NCT07607873

• ctDNA-guided anti-EGFR retreatment in metastatic colorectal cancer

  This project will see if using a ctDNA blood test to pick people with metastatic colorectal cancer for anti‑EGFR retreatment leads to better treatment outcomes.

  Recruiting Niguarda Hospital · Milan, Italia · NCT07536113

• Mapping epigenetic changes that help liver cancer evade the immune system using detailed molecular profiling.

  This project will use tumor and blood samples from people with hepatocellular carcinoma to see if specific noncoding RNAs and epigenetic changes are linked to T cell dysfunction in tumors.

  Recruiting Niguarda Hospital · Milan, Lombardy · NCT07432347

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.